Bridgeway Capital Management »

An2 Therapeutics shares owned by Bridgeway Capital Management

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Bridgeway Capital Management from 13F filings

Historical chart of Bridgeway Capital Management investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Bridgeway Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $224k 104k 2.15
2024-03-31 $85k 26k 3.25
2023-09-30 $764k 48k 16.08
2023-06-30 $234k 28k 8.50
2023-03-31 $518k 53k 9.87